John Buse, Director of the Diabetes Care Center at the University of North Carolina and a principal investigator in GLP-1 outcomes trials, has noted in published commentary that "the antioxidant milieu in type 2 diabetes is genuinely impaired, but whether exogenous supplementation corrects the underlying defect or simply raises circulating levels without tissue impact remains unresolved." [9] That distinction shapes the practical advice: correcting a documented deficiency (measured low whole-blood glutathione in a patient with poorly controlled diabetes) is a different clinical decision from empirically adding glutathione to a well-controlled patient already benefiting from dulaglutide's own oxidative-stress effects
Artificial intelligence and computational modeling can synthesize these datasets to identify novel regulatory networks and therapeutic targets
A biologically based indicator of soil quality
It has been shown to dramatically accelerate the repair of soft tissues, including stubborn tendon-to-bone healing, ligament tears, and damaged cartilage
Legislation Minnesotas SF5046 and HF4881 would repeal the states Prescription Drug Affordability Advisory Council, eliminating an 18-member stakeholder body created to advise the state on prescription drug pricing and affordability issues, representing groups such as patients, providers, insurers, employers, manufacturers, and researchers
Safe & Effective: Dermatologically tested for visible results
